NCT01658956View on ClinicalTrials.gov

Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia

PHASE2UnknownINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Breast Cancer
Interventions
DRUG

GCSF administration on days 8 and 12 after chemotherapy

Trial Locations (1)

1000

RECRUITING

Institut Jules Bordet, Brussels

Sponsors
All Listed Sponsors
lead

Jules Bordet Institute

OTHER